Table 2.
Viables | Cohort N = 510 | NWNT n = 131 | EWNT/NWET n = 194 | HTGW n = 185 | P value a |
---|---|---|---|---|---|
Severity of AP#,& | 0.002 | ||||
MAP | 356 (69.8%) | 101 (77.1%) | 142 (73.2%) | 113 (61.1%) | |
MSAP | 120 (23.5%) | 25 (19.1%) | 43 (22.2%) | 52 (28.1%) | |
SAP | 34 (6.7%) | 5 (3.8%) | 9 (4.6%) | 20 (10.8%) | |
SIRS | 320 (62.7%) | 32 (24.4%)# | 63 (32.5%)& | 95 (51.4%) | 0.000 |
Scores of AP | |||||
Ranson Score | 1.2 ± 1.2 | 1.1 ± 1.1# | 1.1 ± 1.1& | 1.4 ± 1.2 | 0.032 |
CTSI Score | 3.3 ± 2.0 | 2.8 ± 1.5# | 3.3 ± 1.9 | 3.6 ± 2.2 | 0.047 |
Organ failure | 154 (30.2%) | 30 (22.9%)# | 52 (26.8%)& | 72 (38.9%) | 0.004 |
Clinical indicators | |||||
WBC (109/L) | 11.9 ± 4.6 | 10.5 ± 4.2# | 11.8 ± 4.7& | 12.9 ± 4.5 | 0.000 |
GLU (mmol/L) | 8.8 ± 4.0 | 7.3 ± 2.5# | 8.2 ± 3.3& | 10.7 ± 4.8 | 0.000 |
Cr (umol/L) | 60.8(1.5–680) | 63.4(6.3–680) # | 60.8(1.5–430.0) | 57.9(17.0–338.0) | 0.017 |
BUN (mmol/L) | 4.8 ± 2.3 | 5.3 ± 2.7 | 4.6 ± 2.1 | 4.6 ± 2.0 | 0.162 |
LDH (IU/L) | 195.7(4.4–1461.0) | 200 (4.4–786.0) | 200.5(18–860) | 192.0(22.8–1461.0) | 0.893 |
TC (mmol/L) | 4.4(1.1–12.7) | 3.4(1.7–6.5)# | 4.4(1.6–12.7)& | 5.6 (1.1–12.7) | < 0.001 |
TG (mmol/L) | 2.5(0.1–39.2) | 0.9(0.2–1.7)# | 2.4(0.1- 39.2)& | 7.4(1.7–39.0) | < 0.001 |
All the shorthand is shown below: WBC white blood cells,GLU glucose,Cr creatinine,BUN blood urea nitrogen,LDH lactate dehydrogenase,TC total cholesterol,TG triglyceride
arepresents comparing among the three groups;
#The HTGW compared with the NWNT group, P < 0.05
&The HTGW compared with the EWNT/NWET group, P < 0.05